- Research works
- 56 ◆ 1% vs 2013–17
- Citations
- 1.4k 24.2 per fractional work
- Top-10% rate
- 39.8% record average 16.5%
- Open access
- 63% world 28%
Not ranked overall: Insilicos (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 8.9×
- Veterinary 5.1×
- Pharmacology, Toxicology and Pharmaceutics 4.2×
- Immunology and Microbiology 3.2×
- Chemistry 2.1×
- Computer Science 1.6×
- Materials Science 1.4×
- Medicine 1.1×
- Neuroscience 0.3×
- Engineering 0.2×
- Health Professions 0.2×
- Environmental Science 0.2×
- Decision Sciences 0.1×
- Psychology 0.0×
Which keywords describe research at Insilicos (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Machine Learning, Medicinal Chemistry, Molecular Docking, Virtual Screening, Cancer, Molecular Dynamics and Transcriptional Regulation.
- Transcriptional Regulation
- Cancer
- Molecular Docking
- Cancer Therapy
- Machine Learning
- Medicinal Chemistry
- Virtual Screening
- Molecular Dynamics
- Genomics
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Machine Learning3▲ 4.5×5 topics
- Cancer Therapy3▲ 23×9 topics
- Medicinal Chemistry2▲ 40×4 topics
- Molecular Docking2▲ 76×1 topic
- Virtual Screening2▲ 104×1 topic
- Cancer2▲ 5.6×10 topics
- Molecular Dynamics1▲ 38×2 topics
- Transcriptional Regulation1▲ 33×4 topics
- Genomics1▲ 16×2 topics
Which research topics does Insilicos (United States) publish most on?
By volume in 2022–2025: Computational Drug Discovery Methods, Machine Learning in Materials Science, Genetics, Bioinformatics, and Biomedical Research and Biomedical Text Mining and Ontologies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 2 Machine Learning in Materials Science Materials Chemistry 1 works
- 3 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 1 works
- 4 Biomedical Text Mining and Ontologies Molecular Biology 1 works
- 5 Protein Degradation and Inhibitors Molecular Biology 1 works
- 6 Peptidase Inhibition and Analysis Oncology 1 works
- 7 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 8 Protein Structure and Dynamics Molecular Biology 0 works
- 9 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 10 Epigenetics and DNA Methylation Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Insilicos (United States)'s research output changed?
Output in 2018–2022 was 1% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seattle
- University of Washington
- Seattle University
- Fred Hutch Cancer Center
- University of Washington Medical Center
- University of Washington Applied Physics Laboratory
- Seattle Children's Hospital
- Amazon (United States)
- Virginia Mason Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.